Live tumour testing provides short cut to cancer drug development
A technique using live human cancer tissue to develop the next generation of cancer drugs is being developed in South Australia.
Aug 22, 2018
0
29
A technique using live human cancer tissue to develop the next generation of cancer drugs is being developed in South Australia.
Aug 22, 2018
0
29
Few available treatment options exist once prostate cancer has spread to other parts of the body and has failed to respond to therapies that involve blocking the male hormone androgen. Patients with advanced, hormone-refractory ...
Nov 7, 2012
0
0
Researchers at Uppsala University have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been genetically equipped with this T-cell receptor have the ability ...
Sep 13, 2012
0
0
(Medical Xpress) -- Researchers at Imperial College London have discovered a molecule that plays an important role in driving prostate cancer growth, and could be a target for new therapies.
Jul 3, 2012
0
0
A form of radiotherapy targeting the pelvis is safe for men with advanced localised prostate cancer, according to a new study.
Sep 27, 2017
0
1
When it comes to arresting cancer's joyride through the body, one Western researcher's work looks to be the 'traffic cop' on the bloodstream highway.
Jul 25, 2017
0
1
Prostate cancer is the most common male cancer, with 400,000 new cases every year in Europe. The success of surgery depends on a variety of factors. Now a new study from scientists in Milan has shown that for local prostate ...
Mar 11, 2016
0
3
Researchers have identified a sub-group of cells that could contribute to prostate cancer recurrence, opening up new ways to treat the disease, which claims more than 3000 lives a year in Australia.
May 29, 2013
0
0
Cancer of the prostate – the most common male cancer in the UK – presents in two distinct ways: a low-risk type, which may never cause any symptoms, and a high-risk form that needs treatment to prevent it spreading to ...
Oct 29, 2012
0
0
(Medical Xpress)—A new Australian study led by Professor Susan Clark from Sydney's Garvan Institute of Medical Research shows that large regions of the genome – amounting to roughly 2% – are epigenetically activated ...
Dec 18, 2012
0
0